The EMAW platform enables sponsors to achieve better clinical outcomes and enhance study execution
Our single validated technology stack means we collect eCOAs and standardize
multimodal data much faster than legacy platforms, structure it for immediate actionable
insights and facilitate real-time data transfers and access.
The cloud-based EMAW
platform has proven it can uniquely leverage technology, data and AI to generate evidence-based
outcomes with unparalleled precision and greater effect size to meet previously unmet needs in
CNS.
Why the architecture matters
The strength of a single-stack unified platform
Legacy eCOA platforms were built by the acquisition of disparate technologies and these
disconnected
systems preclude real-time insights and complicate data transfers.
The solution
EMAW Unified Platform
Agentic AI for real-time insights.
Clinical Expertise is a Key Differentiation
Our clinical team works with you on study design, which informs platform configuration and generates targeted insights which drive real time decisions impacting subject selection, ratings, and site performance
Study Design
LLM and Agentic Tool Training
Data Interpretation and Analytics
Commercial case
Faster and better clinical decisions and mitigation of study execution risk
The value has its foundation in standardized data collection and storage. This enables real time insights and data access via API or DTS. The canonical data platform generates automated insights via flags and alerts, and derived insights from statistical programs, LLMs and agentic AI tools. The generation of alerts, anomalies and outliers requiring further review protects against clinical and operational risk in real time through faster, more confident decisions.
Screen better
We design screening programs using traditional primary endpoints, ecological momentary assessments, actigraphy, and digital biomarkers which together can trigger reviews of diagnostic interviews to ensure the right subjects are included in a trial.
Detect outliers and other signals earlier
Our canonical database generates access to raw, derivative and transformational data, and uses these data to provide real time insights to study teams which can truncate trial times and preclude rater and site performance issues which can lead to study execution risk. This is all done within our platform and does not require data extracts.
Core capabilities
Real-time insights for better in-study decisions
EMA Wellness integrates eCOA, EMAs, audio/video, sensor data, actigraphy, digital biomarkers, and passively collected Health App data into one clinical trial infrastructure. Standardized, analysis-ready data gives sponsors faster visibility into patient quality, endpoint reliability, operational risk, and emerging treatment signals.
Data foundation
Single cloud-based tech stack and code base to collect multimodal data agnostic to device, API or operating system, including eCOA, EMA, diary, passive health application (phone) and sensor data.
- Utilize LLMs, stats programs and agentic AI models to generate evidence based signals for next generation qualitative enhancements around subject selection, rater surveillance and site quality control
Platform & access
One clinical trial platform for capture, standardization, analysis, and sponsor-side data use.
- Single tech stack across application, browser, data capture, and analytics workflows
- Fewer disconnected systems and fewer manual reconciliation points
- API access for sponsors to access data on demand
- Immediate access to scores for screening, stratification, and quality
- Data outputs built for sponsor analytics environments
Clinical value
We work with sponsors to design their protocols and clearly understand study objectives. We configure our platform to meet these objectives, including which data to collect, when, and how to identify signals which require further review and adjudication. Actionable data supports
- Evidence based subject selection
- Exponentially faster platform configuration and study/site activation
- Faster database lock
- Advanced AI driven rater and site surveillance
- Real time access to raw, derivative and transformational data
- Higher-powered trials run more quickly and efficiently
- Focus on measurement of treatment effect and prediction
